Immunohistochemistry (IHC) Market Growth Outlook Through 2024-2033

Plastic tray of histological tissue samples next to a microscope

Overview and Scope
Immunohistochemistry (IHC) is the technique in diagnosis that uses antibody-antigen interaction to locate particular proteins and antigens in the tissue section. This interaction is visualized using chromogenic detection using enzyme-substrate or fluorescent detection using fluorescent dye.

Sizing and Forecast
The immunohistochemistry (ihc) market size has grown strongly in recent years. It will grow from $2.43 billion in 2023 to $2.65 billion in 2024 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to clinical adoption, industry standardization, expansion in cancer research, automation in laboratories, clinical diagnostics advancements..

The immunohistochemistry (ihc) market size is expected to see strong growth in the next few years. It will grow to $3.77 billion in 2028 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to market entry of new players, demand in drug development, biomedical research integration, diagnostic applications, automation and digitalization.. Major trends in the forecast period include multiplex ihc techniques, digital pathology integration, enhanced antibody specificity, automation and standardization, application in biomarker discovery..

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/immunohistochemistry-ihc-global-market-report

Segmentation & Regional Insights
The immunohistochemistry (ihc) market covered in this report is segmented –

1) By Product: Antibodies, Equipment, Reagents, Kits
2) By Applications: Diagnostics, Drug Testing, Other Applications
3) By End-Users: Hospitals And Diagnostic Laboratories, Research Institutes, Other End-Users

North America was the largest region in the immunohistochemistry (IHC) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the immunohistochemistry (IHC) market report during the forecast period. The regions covered in the immunohistochemistry (ihc) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=9267&type=smp

Major Driver Impacting Market Growth
The increase in the prevalence of chronic diseases is expected to propel the immunohistochemistry (IHC) market going forward. Chronic diseases refer to clinical conditions that last for three months or more extended periods and usually can be controlled but not cured. Immunohistochemistry helps in diagnosing chronic diseases such as cancer, cardiovascular disorders, and others due to its various advantages, such as its specificity, sensitivity (used to detect specific antigens), rapid results, and others. For instance, in 2022, according to the Centers for Disease Control and Prevention, a US-based national public health agency, around 37.3 million people have diabetes which equals 11.3% of the United States population. Therefore, an increase in the prevalence of chronic diseases is driving the growth of the immunohistochemistry (IHC) market.

Key Industry Players

Major companies operating in the immunohistochemistry (IHC) market report are Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, The Merck Group, Danaher Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Bio SB Inc., Agilent Technologies Inc., Abcam PLC, Becton Dickinson and Company, Takara Bio Inc., Biocare Medical LLC, Bio-Genex Laboratories, Diagnostic BioSystems Inc., BioVision Inc., PHC Holdings Corporation, Abbott Laboratories, Leica Biosystems, Vector Laboratories, Indivumed GmbH, Qritive, Ionpath Inc., Reveal Biosciences, Akrivis Technologies Private Limited, LifeSpan BioSciences Inc., Enzo Life Sciences Inc., Epitomics Inc., GenScript Biotech, Histologix Ltd., NeoGenomics Laboratories Inc. .

The immunohistochemistry (ihc) market report table of contents includes:

1. Executive Summary

2. Immunohistochemistry (IHC) Market Characteristics

3. Immunohistochemistry (IHC) Market Trends And Strategies

4. Immunohistochemistry (IHC) Market – Macro Economic Scenario

5. Global Immunohistochemistry (IHC) Market Size and Growth
.
.
.

31. Global Immunohistochemistry (IHC) Market Competitive Benchmarking

32. Global Immunohistochemistry (IHC) Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Immunohistochemistry (IHC) Market

34. Immunohistochemistry (IHC) Market Future Outlook and Potential Analysis

35. Appendix

Explore the trending research reports from TBRC: